Related Experiment Video
Updated: Jun 17, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells
Kazuyuki Sato1, Yusuke Kusama, Moe Tategu
1Department of Life Sciences, Faculty of Agriculture, Meiji University, Tama-ku, Kawasaki, Kanagawa 214-8571, Japan.
Abstract:
Two crucial cell cycle regulators, p16INK4A and p14ARF, are produced from the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene locus by alternative reading frames; these regulators act as tumor suppressors during tumorigenesis. However, the molecular events incidental to the acute functional loss of CDKN2A remain a critical issue. Two pivotal regulatory pathways of cell fate determination involving p16INK4A/retinoblastoma protein (pRb)/E2F1 and p14ARF/p53 interact tightly with each other; however, novel factors with an integral or overlapping role in these two pathways remain incompletely defined. To this end, we specifically decreased the expression of p16INK4A or p14ARF proteins using RNA interference (RNAi) in HeLa cells. Using a DNA microarray approach, we showed that several genes are commonly regulated in both p16INK4A and p14ARF knockdown cells, compared with control RNA-treated cells. We focused on the FBXL16 (F-box and leucine-rich repeat protein 16) gene, the expression of which was reproducibly upregulated in p16INK4A and p14ARF knockdown cells, as evaluated using RT-PCR. Interestingly, the promoter region of FBXL16 was shown to be upregulated by activator E2Fs. Finally, RNAi-mediated knockdown of FBXL16 increased the cell proliferation rate of HeLa cells. Together, our results illustrate a unique aspect of the interdependence between the p16INK4A/pRb/E2F1 and p14ARF/p53 pathways at a molecular level.
Insights
The cyclin-dependent kinase inhibitor 2A (CDKN2A) gene locus produces tumor suppressors p16INK4A and p14ARF. Loss of these proteins commonly upregulates FBXL16, impacting cell proliferation.
Area of Science:
- Molecular biology
- Cell cycle regulation
- Oncology
Background:
- The cyclin-dependent kinase inhibitor 2A (CDKN2A) locus encodes tumor suppressors p16INK4A and p14ARF.
- These proteins are critical regulators of cell cycle control and tumor suppression.
- The molecular consequences of acute CDKN2A loss and the interplay between p16INK4A/pRb/E2F1 and p14ARF/p53 pathways are not fully understood.
Purpose of the Study:
- To investigate the molecular events following the functional loss of p16INK4A and p14ARF.
- To identify novel factors involved in the p16INK4A/pRb/E2F1 and p14ARF/p53 regulatory pathways.
- To elucidate the interdependence of these two critical cell fate pathways.
Main Methods:
- RNA interference (RNAi) was used to specifically decrease p16INK4A or p14ARF expression in HeLa cells.
- DNA microarray analysis identified commonly regulated genes in knockdown cells.
- RT-PCR validated the upregulation of target genes, specifically FBXL16.
- Promoter analysis investigated the regulatory mechanisms of FBXL16.
Main Results:
- Commonly regulated genes were identified in both p16INK4A and p14ARF knockdown cells.
- FBXL16 (F-box and leucine-rich repeat protein 16) expression was reproducibly upregulated in both knockdown conditions.
- The promoter of FBXL16 was found to be upregulated by activator E2Fs.
- Knockdown of FBXL16 using RNAi led to increased cell proliferation rates in HeLa cells.
Conclusions:
- The study reveals a molecular interdependence between the p16INK4A/pRb/E2F1 and p14ARF/p53 pathways.
- FBXL16 is a novel gene commonly regulated by the loss of p16INK4A and p14ARF.
- FBXL16 plays a role in regulating cell proliferation, suggesting its involvement in tumorigenesis.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
